[113th Congress Public Law 233]
[From the U.S. Government Printing Office]



[[Page 128 STAT. 2127]]

Public Law 113-233
113th Congress

                                 An Act


 
  To expand the program of priority review to encourage treatments for 
        tropical diseases. <<NOTE: Dec. 16, 2014 -  [S. 2917]>> 

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled, <<NOTE: Adding Ebola to 
the FDA Priority Review Voucher Program Act.>> 
SECTION 1. <<NOTE: 21 USC 301 note.>> SHORT TITLE.

    This Act may be cited as the ``Adding Ebola to the FDA Priority 
Review Voucher Program Act''.
SEC. 2. PRIORITY REVIEW TO ENCOURAGE TREATMENTS FOR TROPICAL 
                    DISEASES.

    Section 524 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
360n) is amended--
            (1) in subsection (a)(3)--
                    (A) by redesignating subparagraph (Q) as 
                subparagraph (R);
                    (B) by inserting after subparagraph (P) the 
                following:
                    ``(Q) Filoviruses.''; and
                    (C) in subparagraph (R), as so redesignated, by 
                striking ``regulation by'' and inserting ``order of''; 
                and
            (2) in subsection (b)--
                    (A) in paragraph (2), by adding ``There is no limit 
                on the number of times a priority review voucher may be 
                transferred before such voucher is used.'' after the 
                period at the end; and

[[Page 128 STAT. 2128]]

                    (B) in paragraph (4), by striking ``365 days'' and 
                inserting ``90 days''.

    Approved December 16, 2014.

LEGISLATIVE HISTORY--S. 2917:
---------------------------------------------------------------------------

CONGRESSIONAL RECORD, Vol. 160 (2014):
            Dec. 2, considered and passed Senate.
            Dec. 3, considered and passed House.

                                  <all>